ALIM stock news

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 3) Ardelyx Inc (NASDAQ: ARDX ) ( reported positive results from a late-stage of its lead compound tenapanor in combination with phosphate binders to treat hyperphosphatemia in patients with chronic kidney disease on dialysis) China Biologic Products Holdings Inc (NASDAQ: CBPO ) DURECT Corporation (NASDAQ: DRRX ) Insulet Corporation (NASDAQ: PODD ) ( announced private offering of convertible senior notes) Lipocine Inc (NASDAQ: LPCN ) NextCure Inc (NASDAQ: NXTC ) The Medicines Company (NASDAQ: MDCO ) (announced positive Phase 3 results for inclisiran) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 3) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Aduro BioTech Inc (NASDAQ: ADRO ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alimera Sciences Inc (NASDAQ: ALIM ) Assembly Biosciences Inc (NASDAQ: ASMB ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) (announced completion of dose-escalation part of the Phase 1/2a study of AGI-134) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Gemphire Therapeutics Inc (NASDAQ: … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) Castle Biosciences Inc (NASDAQ: CSTL ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 27) Abeona Therapeutics Inc (NASDAQ: ABEO ) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alder Biopharmaceuticals Inc (NASDAQ: ALDR ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alimera Sciences Inc (NASDAQ: ALIM ) AnaptysBio Inc (NASDAQ: ANAB ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Assembly Biosciences Inc (NASDAQ: ASMB ) Cancer Genetics Inc (NASDAQ: CGIX ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Clearside Biomedical Inc (NASDAQ: CLSD ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced that its current cash position will be sufficient to complete enrollment in all three patient groups of its two ongoing Phase 2 trials for its lead compound VAL-083, which is likely to occur by the fourth quarter of 2020) ICU Medical, Incorporated (NASDAQ: ICUI ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Mallinckrodt PLC (NYSE: MNK )(reacted to an unfavorable ruling on a patent infringement lawsuit regarding its inhaled nitric oxide product) Neuralstem, Inc. (NASDAQ: CUR ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Regenxbio Inc (NASDAQ: RGNX ) Revance Therapeutics Inc (NASDAQ: RVNC )(announced an amended agreement with Mylan NV (NASDAQ: MYL ), … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Medpace Holdings Inc (NASDAQ: MEDP )(reported strong second-quarter results ) Novocure Ltd (NASDAQ: NVCR ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 30) Alimera Sciences Inc (NASDAQ: ALIM )(reacted to second-quarter results) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Champions Oncology Inc (NASDAQ: CSBR ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Equillium Inc (NASDAQ: EQ ) Medtronic PLC (NYSE: MDT ) Obseva SA (NASDAQ: OBSV ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) Trevi Therapeutics Inc (NASDAQ: TRVI ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Stocks In Focus Roche Extends Offer Period For Spark Buy Once Again Roche Holdings AG Basel ADR (OTC: RHHBY ) and Spark Therapeutics Inc (NASDAQ: ONCE ) announced Wednesday Roche has extended the offering period for its previously announced tender offer to buy all outstanding shares of Spark for $114.50 … Read more
Alimera Sciences, Inc. (NASDAQ:ALIM) Q1 2019 Earnings Conference Call April 30, 2019 09:00 AM ET Company Participants Scott Gordon - President of Core IR Rick E Read more
Shares of Alimera Sciences Inc (ALIM) are on watch as the Tenkan Line has moved below the Kijun line, indicating negative momentum for the equity. Alimera Sciences Inc moved 0.00 in the most recent se Read more
Alimera Sciences Inc (ALIM) are in focus as we look at near-term expected movement. The reading from the 40-day commodity channel index is currently Hold. The CCI indicator is mainly used to identify Read more
Alimera Sciences, Inc. (NasdaqGM:ALIM) has an ERP5 rank of 17233. The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Ea Read more
Foster & Motley Inc increased Prologis (PLD) stake by 121.38% reported in 2018Q4 SEC filing. Foster & Motley Inc acquired 9,930 shares as Prologis (PLD)’s stock rose 4.44%. The Foster & Motley Inc h Read more
Scholtz & Company Llc increased Abbott Laboratories (ABT) stake by 18.07% reported in 2018Q4 SEC filing. Scholtz & Company Llc acquired 10,087 shares as Abbott Sentiment for Alimera Sciences Inc (ALIM Read more
Tracking some historical stock price data for Alimera Sciences, Inc. (NASDAQ:ALIM), we note that performance has been positive over the last 52-week period. During that time, the stock has risen 1.92% Read more
Examining shares of Alimera Sciences Inc (ALIM), we have seen that the Parabolic SAR is currently above the stock price. Traders tracking this signal may be on the lookout for a possible momentum dire Read more

Proudly made at

ROCKIT